Raffaele Ciampi
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 24, 2026
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 14, 2025
Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience.
Journal: Endocrine-related cancer
Published: July 04, 2025
Multifocality and bilaterality in medullary thyroid cancer: basis for a proof-of-concept safety of lobectomy.
Journal: European thyroid journal
Published: February 27, 2025
Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.
Journal: European journal of endocrinology
Published: February 12, 2025
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: February 11, 2025
Prevalence and genetics of "de novo" MEN2 syndromes.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 09, 2025
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature.
Journal: Endocrine
Published: July 03, 2024
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 22, 2024
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review.
Journal: Journal of clinical medicine
Published: October 02, 2023
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
Journal: Journal of endocrinological investigation
Published: August 10, 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value.
Journal: Biomarker research
Published: June 02, 2023
Last Updated: 09/26/2026